DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Exbivirumab
Exbivirumab
Inclusion and Exclusion Criteria for Each Key Question
(12) United States Patent (10) Patent No.: US 9.468,689 B2 Zeng Et Al
WO 2015/028850 Al 5 March 2015 (05.03.2015) P O P C T
Modifications to the Harmonized Tariff Schedule of the United States To
The Two Tontti Tudiul Lui Hi Ha Unit
Patent Application Publication Oo) Pub. No.: US 2014/0099254 a L Chang Et Al
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Μanagement of Patients with Hepatitis B and C Before and After Liver and Kidney Transplantation
Advice Concerning the Addition of Certain Pharmaceutical Products
(INN) for Biological and Biotechnological Substances
Stembook 2018.Pdf
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
(INN) for Biological and Biotechnological Substances
Strategies to Obtain Diverse and Specific Human Monoclonal
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
A61K9/51 (2006.01) — with International Search Report (Art
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Top View
WO 2U11/1 7921 a L
Wo 2010/095940 A2
Assessment of the Evolution of Cancer Treatment Therapies
Customs Tariff - Schedule Xxi - 1
Tim Malawi Mai Multe
Who Drug Information
Embase 1988 to 2014 Week 36, Ovid MEDLINE(R) In-Process
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
14897/06 ADD 1 ME/Mpd 1 DG E II COUNCIL of the EUROPEAN
WO 2012/109624 A2 16 August 2012 (16.08.2012) P O P C T
Antiviral Therapy in Chronic Hepatitis B Viral Infection During Pregnancy
(INN) for Biological and Biotechnological Substances
Redacted Synopsis
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Supplemental Table 1: Inclusion and Exclusion Criteria